학술논문
Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenström's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenström's Macroglobulinemia
Document Type
Artikel
Author
Buske, C; Dimopoulos, MA; Grunenberg, A; Kastritis, E; Tomowiak, C; Mahe, B; Troussard, X; Hajek, R; Viardot, A; Tournilhac, O; Aurran, T; Lepretre, S; Zerazhi, H; Hivert, B; Leblond, V; de Guibert, S; Brandefors, L; Garcia-Sanz, R; da Silva, MG; Kimby, E; Schmelzle, B; Kaszynski, D; Dreyhaupt, J; Muche, R; Morel, P
Source
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 41(14):2607
Subject
Language
English
English
English
ISSN
1527-7755